# Richard Small

> Richard (Rich) Small is the chief executive officer and a board member of Neurotech Pharmaceuticals. A Northeastern University business graduate and CPA, he joined Neurotech as CFO in July 2007, later adding operating responsibilities. Earlier roles included founding membership and financial leadership at Point Therapeutics, financial leadership at Immulogic, and work at Dennison Manufacturing and Coopers & Lybrand. His public record also includes college trusteeship, local sports coaching and television announcing.

- **Role:** Chief Executive Officer and Board Member at Neurotech Pharmaceuticals, Inc.
- **Organizations:** Neurotech Pharmaceuticals, Inc., Point Therapeutics, Immulogic Pharmaceutical, Dennison Manufacturing Company, Coopers & Lybrand, New England College of Optometry, Medfield TV, Medfield Youth Sports, Medfield Warriors girls hockey
- **Education:** BS in Business Administration, Northeastern University
- **Known for:** Helped take Point Therapeutics public and participated in private and public equity offerings., Worked on multiple licensing deals and public equity offerings at Immulogic., Served as New England College of Optometry trustee from 1995 to 2022; chaired Finance and Business Affairs and served on the Executive Committee for more than 15 years.

## Career timeline

- **Early career** — Began at Coopers & Lybrand; subsequently held financial and treasury positions at Dennison Manufacturing.
- **1995** — CFO of Immulogic during its September $25.8 million gross public offering; began college trusteeship.
- **Before 2007** — Founding member, Senior Vice President and CFO of Point Therapeutics; participated in taking the company public and equity offerings.
- **2007-07** — Point employment ended in management reductions effective July 25; joined Neurotech as CFO in July, with appointment announced August 9.
- **2016-04** — Neurotech announced appointment as COO and CFO.
- **2022** — End of listed 1995-2022 trusteeship at New England College of Optometry.
- **2023-2024** — Medfield girls hockey roster lists Rich Small as assistant coach.
- **2026-10** — Current Neurotech leadership and board pages list Small as CEO and director.

## Achievements

- Helped take Point Therapeutics public and participated in private and public equity offerings.
- Worked on multiple licensing deals and public equity offerings at Immulogic.
- Served as New England College of Optometry trustee from 1995 to 2022; chaired Finance and Business Affairs and served on the Executive Committee for more than 15 years.
- Named among the credited Medfield TV team on the 2016 regional Excellence Awards nonprofessional sports coverage winner.

## Latest updates

- **2026-10** — Neurotech’s current leadership roster continues to list him as chief executive officer and board member.
- **2026-05** — Listed as Neurotech CEO in the Eyecelerator at ARVO 2026 program.
- **2025-09** — Listed as a contributor to Euretina Innovation Spotlight in Paris on September 3, 2025.

## Links

- LinkedIn: https://www.linkedin.com/in/rich-small-92a91032

---

Profile page: https://yespress.io/richard-small
Published by YesPress — https://yespress.io
Last updated: 2026-10-08